US Patent Number

7300651

Publication Date

11-27-2007

Abstract

The present invention provides methods of delaying development of CEA-associated tumors using the anti-idiotype antibody 3H1, particularly in high-risk individuals.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

10/819,493

Filing Date

04/06/2004

Share

COinS